首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer biology & medicine

缩写:

ISSN:2095-3941

e-ISSN:2095-3941

IF/分区:12.4/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1069条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Xin Liang,Xiang Li,Yifei Yao et al. Xin Liang et al.
Objective: This study was aimed at analyzing temporal trends in lung cancer mortality from 2013 to 2021, and projecting future trends until 2030. Methods:...
Zhipeng Qi,Fuqiang Zhao,Xuhua Hu et al. Zhipeng Qi et al.
Early colorectal cancer is often treated through endoscopic procedures to remove tumors. However, when initial removal is incomplete or shows high-risk features, further major surgery is required to ensure no cancer remains. This consensus ...
Xin Jin,Albert M Li,Man Zhao et al. Xin Jin et al.
Objective: The mitochondrial serine catabolic pathway (MSCP) supports tumor proliferation and metastasis, yet no therapies target the MSCP. Because cancer cells rely on the MSCP when respiration is suppressed, we hypothes...
Dayong Hou,Xiangpeng Li,Niyuan Zhang et al. Dayong Hou et al.
Tumor theranostics, which integrates accurate diagnosis and precise therapy, has emerged as a pivotal approach in modern oncology for improving treatment efficacy and reducing off-target toxicity. Click chemistry, which is characterized by ...
Yucheng Qian,Jingsun Wei,Yuan Bian et al. Yucheng Qian et al.
Objective: Colorectal cancer (CRC) progression is driven by cancer stem cells (CSCs) that evade treatment through dynamic phenotype modulation. Our previous research identified BEX2 as a significant regulator of CRC malig...
Na Li,Dexue Tian Na Li
The immune checkpoint blockade (ICB) approach in cancer therapy involves the disruption of immune checkpoint inhibitory signals on tumor-specific CD8+ T cells, thereby reinstating the immune activity of CD8+ T cells and yielding therapeutic...
Ying Zhang,Sicheng Du,Rongrui Liu et al. Ying Zhang et al.
Objective: Conventional tumor-infiltrating lymphocyte (TIL) therapy for solid tumors relies on high-dose interleukin-2 (IL-2) during expansion and post-infusion, and promotes T-cell exhaustion and toxicity. Herein, we dev...